摘要 |
medicine. SUBSTANCE: method involves administering tumor necrosis factor inhibitor at a dose of 0.1 to 200 mg/kg of body mass. The tumor necrosis factor is a protein selected from tumor necrosis factor inhibitor 30 kDa, tumor necrosis factor inhibitor 40 kDa, tumor necrosis factor Δ 53 inhibitor 40 kDa or, tumor necrosis factor Δ 51 inhibitor 40 kDa. EFFECT: enhanced effectiveness in treating lung fibrosis, osteoarthritis, ankylosing spondylitis, lupus erythematosus, gonococcus-induced arthritis, Reiter disease arthritis and gout. 13 cl, 17 dwg, 4 tbl
|